Removal of BRCA1/CtIP/ZBRK1 repressor complex on ANG1 promoter leads to accelerated mammary tumor growth contributed by prominent vasculature.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cancer Cell

• Publication date

  2006-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.CCR.2006.05.022PMID 16843262
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of Brcal is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice

  2007cited by this paper
• CtIP, a candidate tumor susceptibility gene is a team player with luminaries.

  2006cited by this paper
• Genetic Linkage Analysis in Familial Breast and Ovarian Cancer: Results from 214 Families

  2006cited by this paper
• Depletion of BRCA1 impairs differentiation but enhances proliferation of mammary epithelial cells.

  2005cited by this paper
• Angiopoietin 1 causes vessel enlargement, without angiogenic sprouting, during a critical developmental period

  2005cited by this paper
• Inactivation of CtIP Leads to Early Embryonic Lethality Mediated by G1 Restraint and to Tumorigenesis by Haploid Insufficiency

  2005cited by this paper
• Tumorigenesis and Neoplastic Progression Angiopoietin-1 Promotes Tumor Angiogenesis in a Rat Glioma Model

  2004cited by this paper
• Functional Dissection of Transcription Factor ZBRK1 Reveals Zinc Fingers with Dual Roles in DNA-binding and BRCA1-dependent Transcriptional Repression*

  2004cited by this paper
• Correlation of vascular endothelial cell proliferation with microvessel density and expression of vascular endothelial growth factor and basic fibroblast growth factor in hepatocellular carcinoma.

  2004cited by this paper
• Somatic Mutation of p53 Leads to Estrogen Receptor α-Positive and -Negative Mouse Mammary Tumors with High Frequency of Metastasis

  2004cited by this paper
• DNA Damage-Induced Cell Cycle Checkpoint Control Requires CtIP, a Phosphorylation-Dependent Binding Partner of BRCA1 C-Terminal Domains

  2004cited by this paper
• ESE-1 Is a Novel Transcriptional Mediator of Angiopoietin-1 Expression in the Setting of Inflammation*

  2004cited by this paper
• Plasma angiopoietin‐1, angiopoietin‐2 and Tie‐2 in breast and prostate cancer: a comparison with VEGF and Flt‐1

  2003cited by this paper
• Transcriptional Activation of the Cyclin A Gene by the Architectural Transcription Factor HMGA2

  2003cited by this paper
• LIM Kinase 1 Is Essential for the Invasive Growth of Prostate Epithelial Cells

  2003cited by this paper
• Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer

  2003cited by this paper
• LIM kinase 1 is essential for the invasive growth of prostate epithelial cells: implications in prostate cancer.

  2003cited by this paper
• Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1‐related breast carcinoma

  2003cited by this paper
• Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures.

  2003cited by this paper
• A DNA vector-based RNAi technology to suppress gene expression in mammalian cells

  2002cited by this paper
• The RING Heterodimer BRCA1-BARD1 Is a Ubiquitin Ligase Inactivated by a Breast Cancer-derived Mutation*

  2001cited by this paper
• Two Waves of Nuclear Factor κb Recruitment to Target Promoters

  2001cited by this paper
• Familial invasive breast cancers: worse outcome related to BRCA1 mutations.

  2000cited by this paper
• A role for hematopoietic stem cells in promoting angiogenesis.

  2000cited by this paper
• Interaction with endothelial cells is a prerequisite for branching ductal-alveolar morphogenesis and hyperplasia of preneoplastic human breast epithelial cells: regulation by estrogen.

  2000cited by this paper
• Sequence-specific transcriptional corepressor function for BRCA1 through a novel zinc finger protein, ZBRK1.

  2000cited by this paper
• Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response

  2000cited by this paper
• Lessons learned from BRCA1 and BRCA2

  2000cited by this paper
• Angiopoietin‐1 is an apoptosis survival factor for endothelial cells

  1999cited by this paper
• Binding of CtIP to the BRCT Repeats of BRCA1 Involved in the Transcription Regulation of p21 Is Disrupted Upon DNA Damage*

  1999cited by this paper
• Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation

  1999cited by this paper
• Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response.

  1999cited by this paper
• Angiopoietin-1 and its receptor Tie-2 participate in the regulation of capillary-like tubule formation and survival of endothelial cells.

  1999cited by this paper
• A simplified system for generating recombinant adenoviruses.

  1998cited by this paper
• Molecular cloning and characterization of a novel retinoblastoma-binding protein.

  1998cited by this paper
• The C-terminal (BRCT) Domains of BRCA1 Interact in Vivo with CtIP, a Protein Implicated in the CtBP Pathway of Transcriptional Repression*

  1998cited by this paper
• Interaction between a Cellular Protein That Binds to the C-terminal Region of Adenovirus E1A (CtBP) and a Novel Cellular Protein Is Disrupted by E1A through a Conserved PLDLS Motif*

  1998cited by this paper
• BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer.

  1997cited by this paper
• Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development.

  1996cited by this paper
• The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse.

  1996cited by this paper
• Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis.

  1996cited by this paper
• BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner.

  1996cited by this paper
• Aberrant Subcellular Localization of BRCA1 in Breast Cancer

  1995cited by this paper
• The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues

  1995cited by this paper
• Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression

  1995cited by this paper
• Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice.

  1995cited by this paper
• Characterization of the five replication factor C genes of Saccharomyces cerevisiae

  1995cited by this paper
• Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1.

  1994cited by this paper
• Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1 (supplement).

  1994cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

  1993cited by this paper

• Deciphering of SOX9 Functions in Pancreatic Cancer Cells

  2025cites this paper
• The Tumour Microenvironment and Epigenetic Regulation in BRCA1 Pathogenic Variant-Associated Breast Cancers

  2024cites this paper
• ZNF8 promotes progression of gastrointestinal cancers via a p53-dependent mechanism.

  2024cites this paper
• HECW1 induces NCOA4-regulated ferroptosis in glioma through the ubiquitination and degradation of ZNF350

  2023cites this paper
• BRCA1 the Versatile Defender: Molecular to Environmental Perspectives

  2023cites this paper
• Angiopoietin-1 promotes triple-negative breast cancer cell proliferation by upregulating carboxypeptidase A4

  2023cites this paper
• The signaling pathways regulated by KRAB zinc-finger proteins in cancer.

  2022cites this paper
• ZNF498 promotes hepatocellular carcinogenesis by suppressing p53-mediated apoptosis and ferroptosis via the attenuation of p53 Ser46 phosphorylation

  2022cites this paper
• miR-153 as biomarker for cancer—functional role as tumor suppressor

  2022cites this paper
• BRCA1/2 signaling and homologous recombination deficiency in breast and ovarian cancer.

  2021cites this paper
• The Role of BRCA1/2-Mutated Tumor Microenvironment in Breast Cancer

  2021cites this paper
• KRAB-ZFP Transcriptional Regulators Acting as Oncogenes and Tumor Suppressors: An Overview

  2021cites this paper
• Genomic features of rapid versus late relapse in triple negative breast cancer

  2021cites this paper
• BRCA1 and Metastasis: Outcome of Defective DNA Repair

  2021cites this paper
• ZNF354C is a transcriptional repressor that inhibits endothelial angiogenic sprouting

  2020cites this paper
• Human CtIP: A 'double agent' in DNA repair and tumorigenesis.

  2020cites this paper
• PFKP is transcriptionally repressed by BRCA1/ZBRK1 and predicts prognosis in breast cancer

  2020cites this paper
• idenPC-CAP: Identify protein complexes from weighted RNA-protein heterogeneous interaction networks using co-assemble partner relation

  2020cites this paper
• BRCA1 regulates HMGA2 levels in the Swan71 trophoblast cell line

  2019cites this paper
• A molecular basis for Estrogen Receptor- α deficiency in BRCA1-linked breast cancer

  2019cites this paper
• TopicNet: a framework for measuring transcriptional regulatory network change

  2019cites this paper
• Preventing BRCA1/ZBRK1 repressor complex binding to the GOT2 promoter results in accelerated aspartate biosynthesis and promotion of cell proliferation

  2019cites this paper
• Genetic and epigenetic alterations of the EGFR and mutually independent association with BRCA1, MGMT, and RASSF1A methylations in Vietnamese lung adenocarcinomas.

  2019cites this paper
• Functional Evaluation of ZNF350 Missense Genetic Variants Associated with Breast Cancer Susceptibility

  2018cites this paper
• miR-153 inhibits the migration and the tube formation of endothelial cells by blocking the paracrine of angiopoietin 1 in breast cancer cells

  2018cites this paper
• HMGA2 is regulated by LIN28 and BRCA1 in human placental cells†

  2018cites this paper
• KRAB-containing zinc finger protein ZNF496 inhibits breast cancer cell proliferation by selectively repressing ERα activity.

  2018cites this paper
• ZNF350 promoter methylation accelerates colon cancer cell migration

  2018influential citation
• ZNF121 interacts with ZBRK1 and BRCA1 to regulate their target genes in mammary epithelial cells

  2018cites this paper
• The Complex Role of the ZNF224 Transcription Factor in Cancer.

  2017cites this paper
• Five zinc finger protein 350 single nucleotide polymorphisms and the risks of breast cancer: a meta-analysis

  2017influential citation
• New insights into CtIP protein: expression in breast cancer and regulation by sumoylation

  2017cites this paper
• Identification of Acquired Molecular Dependencies in Advanced Breast and Ovarian Cancers

  2017cites this paper
• The Use of Cre – loxP Technology and Inducible Systems to Generate Mouse Models of Cancer

  2017cites this paper
• Exome-capture RNA-sequencing of decade-old breast cancers and matched decalcified bone metastases identifies clinically actionable targets

  2017cites this paper
• Genome-wide predicting disease-related protein complexes by walking on the heterogeneous network based on data integration and laplacian normalization

  2017cites this paper
• TITLE : A Gene Expression Profile of BRCAness That Predicts for Responsiveness to Platinum and PARP Inhibitors PRINCIPAL INVESTIGATOR : Panagiotis Konstantinopoulos CONTRACTING ORGANIZATION :

  2017cites this paper
• By moonlighting in the nucleus, villin regulates epithelial plasticity

  2016cites this paper
• Breast cancer predisposition gene brca1, pathogenic c61g mutation in mice: synthetic viability in DNA repair and tumour development

  2016cites this paper
• Paracrine effect of GTP cyclohydrolase and angiopoietin-1 interaction in stromal fibroblasts on tumor Tie2 activation and breast cancer growth

  2016cites this paper
• Spotting the enemy within: Targeted silencing of foreign DNA in mammalian genomes by the Krüppel-associated box zinc finger protein family

  2015cites this paper
• Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric andTeen Patients Allows Identifying Two Main Classes of Biological ProcessesInvolved and New Potential Therapeutic Targets

  2015cites this paper
• BRCA1, a ‘complex’ protein involved in the maintenance of genomic stability

  2015cites this paper
• ZBRK1, a novel tumor suppressor, activates VHL gene transcription through formation of a complex with VHL and p300 in renal cancer

  2015influential citation
• Understanding the relationship between IRF-1 and the transcriptional repressor ZNF350

  2015influential citation
• Landscape and Targeting of the Angpt-Tie System in Current Anticancer Therapy

  2015cites this paper
• CtIP: A DNA damage response protein at the intersection of DNA metabolism.

  2015cites this paper
• Systematic evaluation of underlying defects in DNA repair as an approach to case-only assessment of familial prostate cancer

  2015cites this paper
• Tetrameric ZBRK1 DNA binding domain has affinity towards cognate DNA in absence of zinc ions.

  2014cites this paper
• MiR-578 and miR-573 as potential players in BRCA-related breast cancer angiogenesis

  2014cites this paper
• Ligand-dependent corepressor contributes to transcriptional repression by C2H2 zinc-finger transcription factor ZBRK1 through association with KRAB-associated protein-1

  2014influential citation
• BRCA1 and Oxidative Stress

  2014cites this paper
• Kruppel-associated box (KRAB) proteins in the adaptive immune system

  2014cites this paper
• The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers.

  2014cites this paper
• Targeting tumor suppressor networks for cancer therapeutics.

  2014cites this paper
• Novel strategies towards the use of anti-angiogenic agents in breast cancer.

  2013cites this paper
• CtIP is required for DNA damage-dependent induction of P21

  2013cites this paper
• Loss of ZBRK1 Contributes to the Increase of KAP1 and Promotes KAP1-Mediated Metastasis and Invasion in Cervical Cancer

  2013cites this paper
• KRAB-Zinc Finger Proteins: A Repressor Family Displaying Multiple Biological Functions

  2013cites this paper
• MiR-146a enhances angiogenic activity of endothelial cells in hepatocellular carcinoma by promoting PDGFRA expression.

  2013cites this paper
• BD-Func: a streamlined algorithm for predicting activation and inhibition of pathways

  2013influential citation
• Analysis of ZNF350/ZBRK1 promoter variants and breast cancer susceptibility in non-BRCA1/2 French Canadian breast cancer families

  2012cites this paper
• MicroRNA expression profiles in hereditary breast cancer

  2012cites this paper
• Angiogenetic axis angiopoietins/Tie2 and VEGF in familial breast cancer

  2012cites this paper
• Integration of BRCA1-mediated miRNA and mRNA profiles reveals microRNA regulation of TRAF2 and NFκB pathway

  2012cites this paper
• ZBRK1 represses HIV‐1 LTR‐mediated transcription

  2012cites this paper
• The Use of Cre–loxP Technology and Inducible Systems to Generate Mouse Models of Cancer

  2012cites this paper
• IL-25 Causes Apoptosis of IL-25R–Expressing Breast Cancer Cells Without Toxicity to Nonmalignant Cells

  2011cites this paper
• Novel Stromal Biomarkers in Human Breast Cancer Tissues Provide Evidence for the More Malignant Phenotype of Estrogen Receptor-Negative Tumors

  2011cites this paper
• The KRAB-containing zinc-finger transcriptional regulator ZBRK1 activates SCA2 gene transcription through direct interaction with its gene product, ataxin-2.

  2011cites this paper
• Regulation of the Angiogenesis Inhibitor Thrombospondin‐1 by the Breast Cancer Susceptibility Gene‐1 (BRCA1)

  2011cites this paper
• A Gene Expression Profile of BRCAness that Predicts for Responsiveness to Platinum and PARP Inhibitors

  2011cites this paper
• Overexpression of HMGA2 Promotes Metastasis and Impacts Survival of Colorectal Cancers

  2011cites this paper
• High-Mobility Group A2 Protein Modulates hTERT Transcription To Promote Tumorigenesis

  2011cites this paper
• Molecular and Cellular Pathobiology Cancer Research Transcriptional Autoregulation by BRCA 1

  2010cites this paper
• ZBRK1 acts as a metastatic suppressor by directly regulating MMP9 in cervical cancer.

  2010cites this paper
• Crosstalk between the DNA damage response, histone modifications and neovascularisation.

  2010cites this paper
• Transcription factor co‐repressors in cancer biology: roles and targeting

  2010cites this paper
• Transcriptional Autoregulation by BRCA 1

  2010cites this paper
• RB·E2F1 Complex Mediates DNA Damage Responses through Transcriptional Regulation of ZBRK1*

  2010cites this paper
• BRCA1 represses amphiregulin gene expression.

  2010influential citation
• Analyse de gènes candidats au cancer du sein impliqués dans les interactions avec BRCA1 et BRCA2

  2010cites this paper
• C-terminal Binding Protein (CtBP) and Poly(ADP)ribose polymerase1 (PARP-1) contribute to repression of the p21waf1/cip1 promoter

  2010cites this paper
• Transcriptional autoregulation by BRCA1.

  2010cites this paper
• Polymorphisms in BRCA1, BRCA1-interacting genes and susceptibility of breast cancer in Chinese women

  2009cites this paper
• Expression of PCNA-binding domain of CtIP, a motif required for CtIP localization at DNA replication foci, causes DNA damage and activation of DNA damage checkpoint

  2009cites this paper
• Derepression of HMGA2 via Removal of ZBRK1/BRCA1/CtIP Complex Enhances Mammary Tumorigenesis*

  2009cites this paper
• ZBRK 1 Acts as a Metastatic Suppressor by Directly Regulating MMP 9 in Cervical Cancer

  2009cites this paper
• Pygo2 expands mammary progenitor cells by facilitating histone H3 K4 methylation

  2009cites this paper
• BRCA1 and BRCA2: Role in the DNA Damage Response, Cancer Formation and Treatment

  2009cites this paper
• Étude du lien fonctionnel entre le suppresseur de tumeur BRCA1 et la machinerie transcriptionnelle à certains gènes en absence ou présence de stress oxydatif in vivo

  2008cites this paper
• Genetic variants and haplotype analyses of the ZBRK1/ZNF350 gene in high‐risk non BRCA1/2 French Canadian breast and ovarian cancer families

  2008cites this paper
• Tie2-R849W mutant in venous malformations chronically activates a functional STAT1 to modulate gene expression.

  2008cites this paper
• Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERα-negative and ERα-positive mammary preneoplasia and cancer

  2008cites this paper
• Breast cancer risk and the BRCA1 interacting protein CTIP

  2008cites this paper
• Cancer: Crossing over to drug resistance

  2008cites this paper
• BRCA1—sowing the seeds crooked in the furrow

  2008cites this paper
• Biological processes, properties and molecular wiring diagrams of candidate low-penetrance breast cancer susceptibility genes

  2008cites this paper
• BRCA1, Hormone, and Tissue-Specific Tumor Suppression

  2008cites this paper
• BRCA1: a new genomic marker for non-small-cell lung cancer.

  2008cites this paper